Screening Strategy Uncovers MAP3K1 Degrader With Potent Preclinical Anticancer Activity
A viability-based phenotypic screening strategy in isogenic knockout cells identified HBC-8, a potent heterobifunctional degrader of MAP3K1 that drives antitumor ...


